Meta-analysis of FOLFIRINOX-based neoadjuvant therapy for locally advanced pancreatic cancer

Currently, the combination of 5-fluorouracil, leucovorin, irinotecan, and oxaliplatin (FOLFIRINOX) is the standard therapy for metastatic pancreatic cancer. In recent years, FOLFIRINOX-based neoadjuvant therapy for locally advanced pancreatic cancer (LAPC) has been gaining an increasing amount of at...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Medicine (Baltimore)
Egile Nagusiak: Chen, Zhiliang, Lv, Yongshuang, Li, He, Diao, Rui, Zhou, Jian, Yu, Tianwu
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Lippincott Williams & Wilkins 2021
Gaiak:
5700
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7837836/
https://ncbi.nlm.nih.gov/pubmed/33546009
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000024068
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak